Vol 10 Issue 4

CELL AND GENE THERAPY INSIGHTS

May 2024 Issue

Vol 10 Issue 4

Download PDF

Featuring

Issue Spotlight: Cell therapy upstream processing and materials
Other articles
Webinars

SPOTLIGHT

Cell therapy upstream processing and materials
Isabelle Rivière
Guest Editor:
Isabelle Rivière, Vice President, Head of Oncology Cell Therapy Technologies and Product Engineer at Takeda

Expert Insight

The sweet cell of success: key considerations for the sourcing and production of pluripotent cell lines for therapeutic development

The sweet cell of success: key considerations for the sourcing and production of pluripotent cell lines for therapeutic development

Samuel JI Blackford, Nathan C Manley
20 May
Read
Raw materials and supplies for cell therapies: end to end expectations and best practices

Raw materials and supplies for cell therapies: end to end expectations and best practices

Lili Belcastro
14 May
Read

Innovator Insight

G-Rex bioreactors incubated in Heracell™ Vios™ CR CO2 Incubators help prevent cross contamination and bacterial contamination in cell and gene modified cell therapy production

G-Rex bioreactors incubated in Heracell™ Vios™ CR CO2 Incubators help prevent cross contamination and bacterial contamination in cell and gene modified cell therapy production

M Kay Bates, D Fick, J Schneider et al.
11 June
Read
An automated 24-hour CAR-T manufacturing process

An automated 24-hour CAR-T manufacturing process

Mina Ahmadi
7 May
Read

Expert Roundtable

iPSC-based therapy dilemmas explored: overcoming hurdles for future success

iPSC-based therapy dilemmas explored: overcoming hurdles for future success

M Carpenter, L Munsie, K Raineri et al.
2 September
Read

Commentary

De-risking pluripotent stem cell therapies

De-risking pluripotent stem cell therapies

Stephen Sullivan, Ricardo Baptista
17 June
Read

Viewpoint

Enabling affordable access to CAR-T cell and other cellular gene therapy products

Enabling affordable access to CAR-T cell and other cellular gene therapy products

R Orentas, Y Xiong, I Oparaocha et al.
12 May
Read

Interview

Planning for success with an allogeneic Treg cell sourcing strategy

Planning for success with an allogeneic Treg cell sourcing strategy

Matthew Breton
22 May
Read
Weighing up the pros and cons of adopting a piecemeal versus a full automation approach to cell therapy manufacture

Weighing up the pros and cons of adopting a piecemeal versus a full automation approach to cell therapy manufacture

Raymond Luke
20 May
Read

Journal articles

Innovator Insight

Enabling and optimizing perfusion for intensified production of CAR-T cells in stirred tank bioreactors

Enabling and optimizing perfusion for intensified production of CAR-T cells in stirred tank bioreactors

Qasim Rafiq, Julia Hengst
14 May
Read
Accelerating cell therapy production: realizing the advantages of rapid analytical testing solutions

Accelerating cell therapy production: realizing the advantages of rapid analytical testing solutions

Seth Peterson
6 May
Read

FastFacts

Leveraging rapid sterility testing to advance cell therapy production

Leveraging rapid sterility testing to advance cell therapy production

Maya Dubey
2 June
Read
Efficient AAV purification with AAVX and AAV9 magnetic beads

Efficient AAV purification with AAVX and AAV9 magnetic beads

Shu Uin Gan
2 June
Read
Intensified production of recombinant vesicular stomatitis virus-based vectors by tangential flow depth filtration

Intensified production of recombinant vesicular stomatitis virus-based vectors by tangential flow depth filtration

Béla Brühlmann, Sven Göbel
22 May
Read
T cell culture process development in stirred-tank bioreactors

T cell culture process development in stirred-tank bioreactors

Stefan Schlößer
20 May
Read

Interview

Fit for function: developing potency assays reflective of the in vivo environment

Fit for function: developing potency assays reflective of the in vivo environment

Giorgio Zenere, Dirk Windgassen
9 May
Read

Webinars